Artwork

Content provided by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Asaf Shiloni of Kadimastem

30:58
 
Share
 

Manage episode 345366251 series 3382134
Content provided by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Asaf Shiloni, a veteran biotech founder and manager is the CEO of Kadimastem a clinical stage biotech company, that is creating cell therapy that enables the production of off-the-shelf cell-based products for the treatment of unmet medical needs such as ALS and a cure for Diabetes. Avraham sat down with Asaf in the offices of Kadimastem to discuss how Kadimastem is creating and testing their innovative therapies, why Israeli startups are so successful, the role of patents in Kadimastem’s business, tips for startup founders and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/asaf-shiloni-of-kadimastem. Listen to all of the episodes at https://jmbdavis.com/podcast.
  continue reading

32 episodes

Artwork
iconShare
 
Manage episode 345366251 series 3382134
Content provided by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Israeli Technology Founders Speak and JMB Davis Ben-David International IP Law Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Asaf Shiloni, a veteran biotech founder and manager is the CEO of Kadimastem a clinical stage biotech company, that is creating cell therapy that enables the production of off-the-shelf cell-based products for the treatment of unmet medical needs such as ALS and a cure for Diabetes. Avraham sat down with Asaf in the offices of Kadimastem to discuss how Kadimastem is creating and testing their innovative therapies, why Israeli startups are so successful, the role of patents in Kadimastem’s business, tips for startup founders and much more. Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup. Also available at https://soundcloud.com/jmbdavis/asaf-shiloni-of-kadimastem. Listen to all of the episodes at https://jmbdavis.com/podcast.
  continue reading

32 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide